CLINICAL_TRIALS
research
· 2024-09-25
Clinical Trial Update: Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial evaluating Yupingfeng Powder for allergic rhinitis, currently not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese University of Hong Kong | Conditions: Allergic Rhinitis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING